SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-24-042447
Filing Date
2024-05-13
Accepted
2024-05-13 17:30:29
Documents
7

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM S-1 ea0205855-s1a3_virpax.htm S-1/A 512965
2 FORM OF PLACEMENT AGENCY AGREEMENT ea020585501ex1-1_virpax.htm EX-1.1 48237
3 FORM OF SECURITIES PURCHASE AGREEMENT TO BE ENTERED INTO IN THIS OFFERING ea020585501ex10-40_virpax.htm EX-10.40 257250
4 CONSENT OF EISNERAMPER LLP ea020585501ex23-1_virpax.htm EX-23.1 2408
5 GRAPHIC image_001.jpg GRAPHIC 4238
6 GRAPHIC image_002.jpg GRAPHIC 23199
7 GRAPHIC image_003.jpg GRAPHIC 21226
  Complete submission text file 0001213900-24-042447.txt   889406
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-278796 | Film No.: 24940498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)